| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |